Results 7,541-7,560 of 8,531 for speaker:Jennifer Carroll MacNeill

Written Answers — Department of Health: Healthcare Policy (17 Jun 2025)

Jennifer Carroll MacNeill: As this is a service matter, I have asked the Health Service Executive to respond directly to the Deputy as soon as possible.

Written Answers — Department of Health: Disability Services (17 Jun 2025)

Jennifer Carroll MacNeill: As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.

Written Answers — Department of Health: Departmental Data (17 Jun 2025)

Jennifer Carroll MacNeill: As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.

Written Answers — Department of Health: Departmental Data (17 Jun 2025)

Jennifer Carroll MacNeill: As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.

Written Answers — Department of Health: Hospital Equipment (17 Jun 2025)

Jennifer Carroll MacNeill: As this is a service matter, I have asked the Health Service Executive to respond to the deputy directly, as soon as possible.

Written Answers — Department of Health: Women's Health (17 Jun 2025)

Jennifer Carroll MacNeill: In 2023 the HSE established a National Vaginal Mesh Implant Oversight Group to oversee vaginal mesh implants in our HSE acute hospitals in terms of both primary implant surgery and tertiary complications services. The focus of this group was to review and assess implementation of the recommendations as set out in the Chief Medical Officer's (CMO’s) report on The Use of...

Written Answers — Department of Health: Medicinal Products (17 Jun 2025)

Jennifer Carroll MacNeill: I propose to take Questions Nos. 923 and 924 together. Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and devices; therefore, I have asked the HSE for an update in this matter. The HSE has advised that there is a National Application, Assessment & Decision Process for...

Written Answers — Department of Health: Departmental Data (17 Jun 2025)

Jennifer Carroll MacNeill: I wish to thank the Deputy for raising this question for review and confirm that my Department has reached out to HIQA to request an update in relation to this matter. My officials will issue you the requested data as soon as possible.

Written Answers — Department of Health: Departmental Data (17 Jun 2025)

Jennifer Carroll MacNeill: As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly.

Written Answers — Department of Health: Departmental Budgets (17 Jun 2025)

Jennifer Carroll MacNeill: The budget allocation of net non-capital expenditure from my Department to HIQA in 2025 is €35m. The figure for 2022 was €21.369m, 2023 was €23.969m and 2024 was €29.318m. HIQA also receive additional funding from my Department for project work such as the National Immunisation Advisory Committee (NIAC) and the National Screening Advisory Committee (NSAC). The...

Written Answers — Department of Health: Health Services Staff (17 Jun 2025)

Jennifer Carroll MacNeill: As this is an operational matter, I have asked the Health Service Executive to respond to the Deputy directly.

Written Answers — Department of Health: Medicinal Products (17 Jun 2025)

Jennifer Carroll MacNeill: The HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Goods) Act 2013. Therefore, I have asked the HSE to provide an update in relation to treatments for SMA patients over 18 years of age. The HSE has advised that once a medicine is approved by the European...

Written Answers — Department of Health: Healthcare Policy (17 Jun 2025)

Jennifer Carroll MacNeill: The Tobacco Free Ireland policy is currently under review. Existing evidence on tobacco and nicotine products will be reviewed as part of this process, and will form the basis of the recommendations made. It is expected that the policy will be published by the end of the year.

Written Answers — Department of Health: Departmental Inquiries (17 Jun 2025)

Jennifer Carroll MacNeill: As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.

Written Answers — Department of Health: Medicinal Products (17 Jun 2025)

Jennifer Carroll MacNeill: Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and devices; therefore, I have asked the HSE for an update in this matter. The HSE has advised that there is a National Application, Assessment & Decision Process for new medicines which is underpinned by Primary Legislation...

Written Answers — Department of Health: Medicinal Products (17 Jun 2025)

Jennifer Carroll MacNeill: Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Written Answers — Department of Health: Judicial Reviews (17 Jun 2025)

Jennifer Carroll MacNeill: The information requested is being collated by Department officials and will be forwarded to the Deputy once available.

Written Answers — Department of Health: Departmental Legal Cases (17 Jun 2025)

Jennifer Carroll MacNeill: Following clarification from the Deputy that this PQ relates to disability assessments of need. This question is appropriate to Department of Children, Disability and Equality who were asked an identical question and will respond accordingly.

Written Answers — Department of Health: Medical Aids and Appliances (18 Jun 2025)

Jennifer Carroll MacNeill: My officials engaged with the Health Products Regulatory Authority (HPRA) who have confirmed that following receipt of a complaint regarding the iD Comfy Junior 8-15 product range, which is classified as a class I medical device, the HPRA initiated market surveillance activities for this product range. This activity is ongoing. Whilst a timeline for completion cannot be determined at...

Written Answers — Department of Health: Hospital Appointments Status (18 Jun 2025)

Jennifer Carroll MacNeill: Under the Health Act 2004, the Health Service Executive (HSE) is required to manage and deliver, or arrange to be delivered on its behalf, health and personal social services. Section 6 of the HSE Governance Act 2013 bars the Minister for Health from directing the HSE to provide a treatment or a personal service to any individual or to confer eligibility on any individual. In relation to...